Juvenile SLE with lupus Anticoagulant and hypoprothrominemia syndrome
Mohammed Olfat, MD1. Ahmed Tarawah, MD2. Doaa Mohammed3. Meyasser Olfat4.

•	¹ Division of Rheumatology, Maternity and Children Hospital 
•	2 Division of Hematology, Maternity and Children Hospital 
•	3 Division of paediatrics, Maternity and Children Hospital
•	4 Medical school, Taibah University

•	Corresponding Author:
•	Mohammed Olfat, MD 
•	Division of Rheumatology
•	Maternity and Children Hospital 
•	Prince Abdul Majeed Road
•	Medina, Saudi Arabia
•	Phone: +966-5-04356467
•	Fax: +966-14-8640915
•	e-mail: mmmoholfat@yahoo.com
Abstract
Lupus anticoagulant and hypoprothrombinemia syndrome (LAC–HPS) is a rare clinical entity that can occur in association with juvenile SLE.  We described a girl with systemic lupus erythematosus who developed hemorrhagic tendencies as a consequence of a clotting factor II (prothrombin) deficiency. She responded rapidly to treatment with corticosteroids and the coadministration of vitamin K and fresh frozen plasma. The addition of cellcept has enabled the control of disease manifestations and the reduction in steroid doses.